"Gain inspiration and critical insights from global thought leaders addressing critical topics at the intersection of science, business and policy. The 2022 BIO International Convention will feature 100+ interactive sessions across 4 days covering a variety of therapeutic areas, business development, digital health, patient advocacy, public policy, and next-generation biotherapeutics, and the latest updates from industry experts on COVID-19 and the vaccine. "

Bloom Burton is hosting its annual Healthcare Investor Conference in Toronto, Canada. They’ve invited 66 of Canada’s premier publicly-traded and venture-backed private companies together with the most promising pre-venture companies in the healthcare industry.

Health data can save lives and keep BC and Canada competitive on the global stage — from genomics through developing AI solutions that cure disease. Data can help us diagnose and treat illness earlier and more effectively, accelerate preventative and precision medicine, unlock how environmental factors can determine health outcomes, and more. 
 
To unleash the full potential of this data, we need robust cyber and privacy security, advanced data sharing and integration tools, as well as decentralized platforms that Canadians can trust. These tools exist, and Canada should be a leader in their implementation.

On April 7, 2022, CityAge, in collaboration with Genome BC, WesGroup, Estonia, Digital Technology Super Cluster, and St. Paul's Fondation launched the next epsiode for The Data Effect, Data-Driven Healthcare Breakthroughs and mapped out how Canada can use these assets to drive discovery, protect privacy, and benefit society. 

Ali Ardakani was moderating the panel: Data-Driven Health Care Breakthroughs

Open and accessible data sets can accelerate health research. What are the essential components of a great health science cluster? How do we ensure the privacy that Canadians expect, while also driving discovery that can save lives? What’s the role of data sharing and data policy? 

• Zsuzsanna Hollander, Data Science Lead, Genome BC 
• Marc Fiume, Co-Founder and CEO, DNAstack  
• Kim McGrail, Scientific Director, Health Data Research Network Canada, Professor, UBC 
• Darryl Knight, Vice President, Research and Academic Affairs, Providence Health Care   
• ‍Moderator: Ali Ardakani, Founder & Managing Director, Novateur Ventures, Vice Chair, LifeSciences BC

2022 will mark the 7th Annual Access to Innovation Conference, bringing together all stakeholders in the life sciences sector. The conference brings together leaders from across academia, research, health institutions, government, and industry. Broadly, the aim of the conference is to provide a venue for dialogue on topics of relevance to life sciences from scientific discovery, emerging trends, innovation, economic impact, translational science, and policies to advance the sector.

Join us for the sessions sponsored by Novateur Ventures and moderated by Ali Ardakani, Novateur's Founder & Managing Director and Vice-Chair of LifeSciences BC:

How to Build a Successful AI/Medtech Company: Canary Medical’s Story

Speaker: Dr. William Hunter, President & CEO, Canary Medical Inc.
February 17, 2022 at 11:00 AM - 11:30 AM Pacific time

How mRNAs Saved the World: Pieter Cullis’ Journey

Speaker: Dr. Pieter Cullis, Scientific Director & CEO, NanoMedicines Innovation Network
February 17, 2022 at 12:00 PM - 12:30 PM Pacific time

Panel Investment in BC Life Sciences: Super Hero Investors

Ali Ardakani, Vice-Chair of Life Sciences BC and Founder & Managing Director of Novateur Ventures was leading a panel discussion on Super Hero Investors in the BC life sciences sector with some of the most active invstors in the region.

Invest in BC presented by Lumira Ventures is our opportunity to bring together stakeholders in the healthcare innovation ecosystem. Entrepreneurs tell their stories and get feedback and engagement from a wide range of investor stakeholders. Investor participants range from angel investors, venture capital, corporate venture, and foundations. In addition, tech transfer offices, innovation councils, and government ministries and agencies are also present. It is the opportunity for companies to attract attention, solicit support, and secure investment that will aid them in their continued growth trajectory.
 
The event brings together stakeholders in the life sciences ecosystem for an exciting day of innovative company pitches, presentations, and engaging panel discussions. Companies from across the life sciences community will be invited to apply to pitch from the following sectors: Digital Health, Medical Devices, Medical Technology, Diagnostics, and Biotechnology.
 
Last year’s Investor Summit attracted 85 investors from around the world including from the UK, USA, China, Singapore & India. 

The 23rd Annual Life Sciences BC Awards is an opportunity to celebrate our community’s many achievements, small wins and big victories, with our peers, family and friends. This is our moment to recognize and honour the efforts of all those who have invested their lives’ work in mastering successful health outcomes.

B.C. has found its place on the international life sciences stage and is recognized in Canada and beyond for its significant accomplishments in medical technology, biopharmaceuticals, health delivery systems, and medical research & development initiatives. We have reached beyond our borders to impact patient health and connect to the world at large, while ensuring the life science sector here, at home, remains vibrant and sustainable.

We are fortunate to have a life science ecosystem that bridges academia and a thriving research & development networks, including world-class healthcare facilities, distinguished health & medical foundations, and renowned centres of excellence that are supportive of translation and commercializing innovation in healthcare.

The 2021 Life Sciences BC Award Winners are: 

Company

• Life Sciences Company of the Year – AbCellera 
• Medical Technology Company of the Year – Kardium 
• Deal of the Year –Aurinia Pharmaceuticals Inc. 
• Strategic Life Sciences Partner of the Year – Novateur Ventures 
• Emerging Life Sciences Company of the Year – Notch Therapeutics

Individual 

• Milton Wong Award for Leadership – Northview Ventures: Doug Janzen 
• Dr. Don Rix Award for Achievement in Life Sciences – Dr. Helen Burt 

Research 

• Genome BC Award for Scientific Excellence – Dr. Michael Russello 
• Michael Smith Foundation for Health Research – Aubrey J. Tingle Prize – Dr. Ruth Grunau 

Impact 

BC Life Sciences innovation has been globally recognized for addressing the unique challenges that arose as a result of the pandemic. Through collaboration between academic and research institutions, local SME and global pharmaceutical companies, we saw BC take a leadership role in the development of vaccines, therapeutics, medical devices and diagnostics, and digital health solutions. While many BC companies and individuals have contributed greatly, Life Sciences BC would like to recognize the extraordinary efforts made within our sector with two special awards that celebrate leadership. 

• Global Impact Award: Company – Acuitas Therapeutics 
• Leadership Impact Award: Individual – Dr. Mel Krajden, BC Centre for Disease Control 

Please join us in celebrating our 2021 Life Sciences BC Award winners

Date: September 23, 2021

Time: 2:00pm to 4:30pm PT

Platform: Zoom

Tickets: Free for Life Sciences BC members & non-members

How to make money from your IP portfolio?

IP is one of the key components in both early-stage and well-established companies, therefore for medtech, digital health and biotech start-ups its crucial to develop a strong patent strategy right from the start.

ELAVITY jointly with the law firm Vossius & Partner, Swiss Federal Institute of Intellectual Property and Novateur Ventures, invites you to this Masterclass on Intellectual Property for New Ventures. A variety of topics will be covered as described in below and the strategic importance of IP and licensing in the context of fundraising will be highlighted.

Topics:

• Deep dive into Intellectual Property definition as a key value driver
• Short introduction to the common IP rights else than patents (trademarks, designs and copyright)
• Patents and patentability criteria (technicality, industrial application, novelty and inventive steps)
• Applications of Intellectual Property
• How to use IP to protect your business
• Common strategies to extend protection beyond the 20-year term
• Developing a compelling IP Portfolio
• How to make money from your IP Portfolio

The June VANTEC event features thought leaders who will provide some insights into the trends and future of the life and health sciences sector; followed by presentations from life sciences and healthtech companies. Join us for an afternoon of investor panels, pitches, and networking.

Join Novateur Ventures Inc.'s Managing Director Ali Ardakani and ESSA Pharma' s President & CEO David Parkinson for a session about the journey from discovery to successful clinical trials at the  LifeSciences BC Access to Innovation event.

Session 3: Part 2, Wednesday, Feb 24, 1:30 PM - 2:00 PM PST
Theme: "From Discovery to Successful Clinical Trials: ESSA Pharma’s Story"

Join Novateur Ventures Inc.'s Managing Director Ali Ardakani and Kardium Inc.' s CEO Kevin Chaplin on Wednesday, Feb 24, 12:30 PM - 1:00 PM (PST) for a session about successful medical device commercialization at the LifeSciences BC Access to Innovation event.

Learning the “in’s and out’s” of fundraising is a key element of an entrepreneur's venture building journey. But even more important is building relationships with potential investors, as these are the champions that can provide guidance, open doors and provide valuable insights to navigate from what, when and how to fundraise.

Join our Reverse Pitch Roundtables following our Sneak-a-Peek presentations with Ali Ardakani of Novateur Ventures Inc. Ventures, Irene Dorsman of Angel Forum ™ Vancouver and Women's Equity Lab and Pieter Dorsman of Angel Forum ™ Vancouver and E-Fund. 

Please join Novateur Ventures Inc.'s Founder & Managing Director and Vice-Chair of LifeSciences BC, Ali Ardakani for the panel discussion on investment in the BC life sciences sector with some of the most active investors in the region.

The LifeSciences BC Investor Summit brings together industry stakeholders from the healthcare innovation ecosystem for company pitching and fostering strategic partnerships with international investors. This signature event will profile more than 30 digital health, therapeutics, and medical technology entrepreneurs from British Columbia’s life sciences sector. 

Each of the selected companies will have the opportunity to present their company’s story and receive feedback and engagement from a wide range of investor stakeholders including, angel investors, venture capitalists, and corporate ventures from Japan, France, Hong Kong, China, the United States and Canada.

For 2020, the BIO International Convention will transition to a new, virtual event format, BIO Digital. This virtual gathering of the global biotech industry provides access to key partners via BIO One-on-One Partnering, educational resources to help drive your business, and the insights you need to continue critical research and development. 

We may not be able to gather in person, but nothing stops innovation.

The highly successful fourteenth annual Bio-Europe Spring® international partnering conference was a fully digital event in the midst of the worldwide travel restrictions due to the global health emergency. In just 16 days, EBD Group transformed what would have been a Paris conference, to a digital solution. 

This year’s theme is “Innovation Adoption – Accelerating Patient Outcomes”. Stakeholders include: Academia, Health Institutions, Government, Centres of Innovation, SMEs, Multi-national Corporations, Investors and Payers.

The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.

What is today known as the annual J.P. Morgan Healthcare Conference began in 1983 and was hosted by Hambrecht & Quist (H&Q). H&Q was acquired by Chase in 2000 and a year later Chase was acquired by J.P. Morgan. At its infancy, the conference featured just 20 companies, had about 200 attendees and focused on the biotech industry.

Today, while it is still at the Westin St. Francis in San Francisco, the annual J.P. Morgan Healthcare Conference brings thousands of investors from around the world together. The hundreds of companies presenting run the gamut, from start-ups to those with more than $300 billion in market cap, and encompass the entire global healthcare landscape, including pharmaceutical firms, healthcare service providers, profit and not-for-profits, and medical device companies.

As Europe’s largest life science partnering conference, BIO-Europe offers countless opportunities to engage with global life science partners. Empower yourself with knowledge from key biotech and pharma leaders who will discuss the latest industry trends in workshops and panels.

The Prix Galien Award recognizes outstanding achievements in improving the global human condition through the development of innovative drugs and other treatments. The Prix Galien was created in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

The Prix Galien USA Awards Ceremony launched in 2007 and the Awards Ceremony and Dinner is held annually at the New York City Museum of Natural History following the Galien Forum. In recognition of the development and discovery of products that improve the human condition, a committee of highly accomplished scientific leaders, inclusive of four Nobel Laureates, recognized winners in three categories: “Best Pharmaceutical Product,” “Best Biotechnology Product,” and “Best Medical Technology.”

Join SynBioBeta 2019 on October 1-3 in San Francisco to see how synthetic biology is disrupting consumer products, food, agriculture, medicine, chemicals, materials, and more.

Bestowed annually, the Bloom Burton Award honours an individual scientist, inventor, executive, entrepreneur, industry leader, or policy maker who made the greatest contribution to Canada’s innovative healthcare industry in the previous year.

Follow the news and you know: Scientists are more than just chipping away at cancer. They are kicking down the barricades. Cell therapies are, at long last, delivering lasting remissions in a few indications. Small molecules and antibodies with new mechanisms of action – sometimes in clever combination – are raising the bar, making cancer more of a chronic and tolerable disease. Underlying information on gene mutations, dysregulated protein networks and the tumor microenvironment provide a vivid glimpse of malignancy at the molecular level, and a wellspring for new therapeutic ideas. Much of this progress is occurring here on the West Coast. Hear from the leaders in Big Biotech, venture capital, and emerging startups at The Seattle Cancer Summit, March 5 and at The Boston Cancer Summit, March 7. All proceeds go to the Mt. Everest Climb to Fight Cancer campaign at Fred Hutchinson Cancer Research Center.

Follow the news and you know: Scientists are more than just chipping away at cancer. They are kicking down the barricades. Cell therapies are, at long last, delivering lasting remissions in a few indications. Small molecules and antibodies with new mechanisms of action – sometimes in clever combination – are raising the bar, making cancer more of a chronic and tolerable disease. Underlying information on gene mutations, dysregulated protein networks and the tumor microenvironment provide a vivid glimpse of malignancy at the molecular level, and a wellspring for new therapeutic ideas. Much of this progress is occurring here on the West Coast. Hear from the leaders in Big Biotech, venture capital, and emerging startups at The Seattle Cancer Summit, March 5 and at The Boston Cancer Summit, March 7. All proceeds go to the Mt. Everest Climb to Fight Cancer campaign at Fred Hutchinson Cancer Research Center.